Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol
Authors:
- 1 October 1991
- journal article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 86 (3) , 163-173
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic systemJournal of Neural Transmission, 1990
- Striatal binding of11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor bindingJournal of Neural Transmission, 1990
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- 3-(2'-[18F]Fluoroethyl)Spiperone: In vivo Biochemical and Kinetic Characterization in Rodents, Nonhuman Primates, and HumansJournal of Cerebral Blood Flow & Metabolism, 1989
- Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levelsPsychopharmacology, 1989
- Clinical pharmacokinetics of clozapine in chronic schizophrenic patientsEuropean Journal of Clinical Pharmacology, 1988
- Dopamine receptors and the dopamine hypothesis of schizophreniaSynapse, 1987
- 3-N-(2-[18F]-fluoroethyl)-spiperone: A novel ligand for cerebral dopamine receptor studies with petLife Sciences, 1986
- Performance Study of the PC-384 Positron Camera System for Emission Tomography of the BrainJournal of Computer Assisted Tomography, 1984
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977